Antithrombotic Therapy and Mortality Risk in Older Adults with Hip Fractures
VKA use is associated with significantly higher mortality in older patients with hip fracture and may identify a subset at substantial risk of poor outcomes. These findings underscore the need for careful assessment and management of VKA users and further research to confirm these observations.
Authors
- Fabienne Magdelijns
- Mark van den Boogaart
- Renée A. G. Brüggemann (ORCID: https://orcid.org/0000-0003-1482-4708)
- Steffie H. A. Brouns
- Nordin M.J. Hanssen (ORCID: https://orcid.org/0000-0001-9541-7244)
- Martijn Poeze (ORCID: https://orcid.org/0000-0001-5005-1285)
- Bart Spaetgens (ORCID: https://orcid.org/0000-0003-3062-2612)
- Nick van Es (ORCID: https://orcid.org/0000-0001-5256-6346)
- M Jong (ORCID: https://orcid.org/0009-0007-2799-2491)
- Karin Vleeshouwers
- Janneke J. C. Bastings
Institutions
- Maastricht University Medical Centre (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Maastricht University (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Journal of the American Medical Directors Association
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1016/j.jamda.2025.105690
- Citations
- 1
- Primary Topic
- Hip and Femur Fractures
- Type
- article
- Field-Weighted Citation Impact
- 2.01